Antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae.
作者信息
Hammerschlag M R
机构信息
Department of Pediatrics, State University of New York Health Science Center at Brooklyn 11203-2098.
出版信息
Antimicrob Agents Chemother. 1994 Sep;38(9):1873-8. doi: 10.1128/AAC.38.9.1873.
Abstract
摘要
相似文献
1
Antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae.肺炎衣原体所致感染的抗菌药敏性及治疗
Antimicrob Agents Chemother. 1994 Sep;38(9):1873-8. doi: 10.1128/AAC.38.9.1873.
2
In vitro activity of midecamycin diacetate against Mycoplasma pneumoniae and Chlamydia pneumoniae.麦迪霉素二醋酸酯对肺炎支原体和肺炎衣原体的体外活性。
J Antimicrob Chemother. 2001 Feb;47(2):240-1. doi: 10.1093/jac/47.2.240.
3
Activity of Levonadifloxacin (WCK 771) against Chlamydia pneumoniae.左氧氟沙星（WCK 771）对肺炎衣原体的活性。
Antimicrob Agents Chemother. 2019 Jul 25;63(8). doi: 10.1128/AAC.01048-19. Print 2019 Aug.
4
Potential for antimicrobial resistance in Chlamydia pneumoniae.肺炎衣原体的抗菌耐药潜力。
J Infect Dis. 2000 Jun;181 Suppl 3:S456-9. doi: 10.1086/315608.
5
[Diagnosis and therapy of Chlamydia pneumoniae and trachomatis].肺炎衣原体和沙眼衣原体的诊断与治疗
Internist (Berl). 1997 Oct;38(10):995-6.
6
Efficacy of benzoxazinorifamycins in a mouse model of Chlamydia pneumoniae lung infection.苯并恶嗪诺利福霉素在肺炎衣原体肺部感染小鼠模型中的疗效。
Antimicrob Agents Chemother. 2008 May;52(5):1855-8. doi: 10.1128/AAC.01567-07. Epub 2008 Mar 10.
7
Microbiological efficacy of levofloxacin for treatment of community-acquired pneumonia due to Chlamydia pneumoniae.左氧氟沙星治疗肺炎衣原体所致社区获得性肺炎的微生物学疗效。
Antimicrob Agents Chemother. 2000 May;44(5):1409. doi: 10.1128/AAC.44.5.1409-1409.2000.
8
Susceptibilities to clarithromycin and erythromycin of isolates of Chlamydia pneumoniae from children with pneumonia.肺炎患儿肺炎衣原体分离株对克拉霉素和红霉素的敏感性
Antimicrob Agents Chemother. 1994 Jul;38(7):1588-9. doi: 10.1128/AAC.38.7.1588.
9
Microbiologic efficacy of azithromycin and susceptibilities to azithromycin of isolates of Chlamydia pneumoniae from adults and children with community-acquired pneumonia.阿奇霉素对成人和儿童社区获得性肺炎患者肺炎衣原体分离株的微生物学疗效及肺炎衣原体分离株对阿奇霉素的敏感性
Antimicrob Agents Chemother. 1998 Jan;42(1):194-6. doi: 10.1128/AAC.42.1.194.
10
Collaborative multidisciplinary workshop report: detection, culture, serology, and antimicrobial susceptibility testing of Chlamydia pneumoniae.协作多学科研讨会报告：肺炎衣原体的检测、培养、血清学及抗菌药敏试验
J Infect Dis. 2000 Jun;181 Suppl 3:S460-1. doi: 10.1086/315599.
引用本文的文献
1
From coughs to complications: the story of .从咳嗽到并发症：……的故事
J Med Microbiol. 2025 Apr;74(4). doi: 10.1099/jmm.0.002006.
2
Chlamydia Serine Protease Inhibitor, targeting HtrA, as a New Treatment for Koala Chlamydia infection.靶向HtrA的衣原体丝氨酸蛋白酶抑制剂作为考拉衣原体感染的新疗法。
Sci Rep. 2016 Aug 17;6:31466. doi: 10.1038/srep31466.
3
N-acylated derivatives of sulfamethoxazole and sulfafurazole inhibit intracellular growth of Chlamydia trachomatis.磺胺甲恶唑和磺胺异恶唑的N-酰化衍生物可抑制沙眼衣原体的细胞内生长。
Antimicrob Agents Chemother. 2014 May;58(5):2968-71. doi: 10.1128/AAC.02015-13. Epub 2014 Feb 24.
4
Chlamydia pneumoniae pneumonia: An evolving clinical spectrum.肺炎衣原体肺炎：不断演变的临床谱。
Can J Infect Dis. 1995 Jul;6(4):191-5. doi: 10.1155/1995/574107.
5
Chlamydia pneumoniae infection and Alzheimer's disease: a connection to remember?肺炎衣原体感染与阿尔茨海默病：值得记住的关联？
Med Microbiol Immunol. 2010 Nov;199(4):283-9. doi: 10.1007/s00430-010-0162-1. Epub 2010 May 6.
6
Isolation and antimicrobial susceptibilities of Chlamydial isolates from Western barred bandicoots.西澳毛尾袋小鼠衣原体分离株的分离及药敏试验
J Clin Microbiol. 2007 Feb;45(2):392-4. doi: 10.1128/JCM.01726-06. Epub 2006 Nov 22.
7
Frequency of spontaneous mutations that confer antibiotic resistance in Chlamydia spp.衣原体属中赋予抗生素抗性的自发突变频率
Antimicrob Agents Chemother. 2005 Jul;49(7):2865-73. doi: 10.1128/AAC.49.7.2865-2873.2005.
8
In vitro activities of garenoxacin and levofloxacin against Chlamydia pneumoniae are not affected by presence of Mycoplasma DNA.加替沙星和左氧氟沙星对肺炎衣原体的体外活性不受支原体DNA存在的影响。
Antimicrob Agents Chemother. 2004 Jun;48(6):2081-4. doi: 10.1128/AAC.48.6.2081-2084.2004.
9
In vitro activities of BMS-284756 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae.BMS-284756对沙眼衣原体及肺炎衣原体近期临床分离株的体外活性
Antimicrob Agents Chemother. 2002 Feb;46(2):517-8. doi: 10.1128/AAC.46.2.517-518.2002.
10
The Role of Chlamydia in Upper Respiratory Tract Infections.衣原体在上呼吸道感染中的作用。
Curr Infect Dis Rep. 2000 Apr;2(2):115-120. doi: 10.1007/s11908-000-0023-y.
本文引用的文献
1
In vitro and in vivo antichlamydial activities of newly developed quinolone antimicrobial agents.新开发的喹诺酮类抗菌剂的体外和体内抗衣原体活性。
Antimicrob Agents Chemother. 1993 Apr;37(4):801-3. doi: 10.1128/AAC.37.4.801.
2
Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries.肺炎衣原体在冠状动脉粥样硬化病变中的证实。
J Infect Dis. 1993 Apr;167(4):841-9. doi: 10.1093/infdis/167.4.841.
3
Treatment of community-acquired pneumonia. A multicenter, double-blind, randomized study comparing clarithromycin with erythromycin. Canada-Sweden Clarithromycin-Pneumonia Study Group.社区获得性肺炎的治疗。一项比较克拉霉素与红霉素的多中心、双盲、随机研究。加拿大-瑞典克拉霉素-肺炎研究组。
Chest. 1993 Mar;103(3):697-701. doi: 10.1378/chest.103.3.697.
4
New oral macrolide and fluoroquinolone antibiotics: an overview of pharmacokinetics, interactions, and safety.新型口服大环内酯类和氟喹诺酮类抗生素：药代动力学、相互作用及安全性概述
Clin Infect Dis. 1993 Aug;17 Suppl 1:S192-9. doi: 10.1093/clinids/17.supplement_1.s192.
5
The in-vitro activity of OPC-17116, a new 5-methyl substituted quinolone.新型5-甲基取代喹诺酮OPC-17116的体外活性
J Antimicrob Chemother. 1993 Apr;31(4):497-504. doi: 10.1093/jac/31.4.497.
6
Influence of temperature and relative humidity on the survival of Chlamydia pneumoniae in aerosols.温度和相对湿度对肺炎衣原体在气溶胶中存活的影响。
Appl Environ Microbiol. 1993 Aug;59(8):2589-93. doi: 10.1128/aem.59.8.2589-2593.1993.
7
A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island. Evidence of serologic cross-reactivity.罗德岛肺炎衣原体血清流行病学研究。血清学交叉反应的证据。
Chest. 1993 Jul;104(1):208-13. doi: 10.1378/chest.104.1.208.
8
In vitro activity of azithromycin (CP-62,993) against Chlamydia trachomatis and Chlamydia pneumoniae.阿奇霉素（CP - 62,993）对沙眼衣原体和肺炎衣原体的体外活性。
Antimicrob Agents Chemother. 1993 Sep;37(9):1746-8. doi: 10.1128/AAC.37.9.1746.
9
Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis.肺炎衣原体可引发肺炎和支气管炎的证据。
J Infect Dis. 1993 Nov;168(5):1231-5. doi: 10.1093/infdis/168.5.1231.
10
In vitro activities of OPC-17116, a new quinolone; ofloxacin; and sparfloxacin against Chlamydia pneumoniae.新型喹诺酮类药物OPC - 17116、氧氟沙星及司帕沙星对肺炎衣原体的体外活性
Antimicrob Agents Chemother. 1994 Jun;38(6):1402-3. doi: 10.1128/AAC.38.6.1402.
Zotero 插件